Alumis (ALMS) Total Liabilities (2023 - 2026)
Alumis (ALMS) posted quarterly Total Liabilities of $110.6 million for Q4 2025, up 36.79% year-over-year from $80.9 million in Q4 2024, and up 7.17% quarter-over-quarter from $103.2 million in Q3 2025.
Alumis (ALMS) Total Liabilities (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Total Liabilities for 3 consecutive years, with $110.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities rose 36.79% year-over-year to $110.6 million; the TTM figure through Dec 2025 stood at $110.6 million (up 36.79% YoY), while the FY2025 annual figure was $110.6 million, up 36.79% from the prior year.
- Total Liabilities grew to $110.6 million in Q4 2025 per ALMS's latest filing, from $103.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $125.6 million in Q2 2025 and bottomed at $53.5 million in Q4 2023.
- Historically, Total Liabilities has averaged $87.0 million across 3 years, with a median of $86.9 million in 2024.
- On a YoY basis, Total Liabilities climbed as much as 94.13% in 2025 and fell as far as 36.79% in 2025.
- Alumis' Total Liabilities stood at $53.5 million in 2023, then jumped by 51.19% to $80.9 million in 2024, then jumped by 36.79% to $110.6 million in 2025.
- Business Quant data shows ALMS's Total Liabilities at $110.6 million in Q4 2025, $103.2 million in Q3 2025, and $125.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - | 108.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.46 Mn |
| Dec 31, 2025 | 110.64 Mn |
| Sep 30, 2025 | 103.24 Mn |
| Jun 30, 2025 | 125.60 Mn |
| Mar 31, 2025 | 92.98 Mn |
| Dec 31, 2024 | 80.89 Mn |
| Sep 30, 2024 | 64.17 Mn |
| Jun 30, 2024 | 64.70 Mn |
| Dec 31, 2023 | 53.50 Mn |